Tumor size, depth of tumor invasion (pT3–4 vs pT1-2), lymph node metastasis (positive vs negative) and low expression of ZSCAN18 predicted an increased risk of cancer-related death in univariate analysis (Table 1). Here, ZSCAN18 is linked to cancer.